Endowed Chair

Endowed Chair

In 1986, the Century Mortar Club helped raise $500,000 to establish an endowed chair in pharmacy management. Through club funds, additional gifts from members and fund-raising efforts by CMC members the club reached its goal. The $500,000 was then matched from a permanent University Fund, where the interest raised helps support the Endowed Chair of the Century Mortar Club, Dr. Stephen W. Schondelmeyer.

Stephen W. Schondelmeyer

Dr. Schondelmeyer is a professor of Pharmaceutical Economics in the College of Pharmacy at the University of Minnesota, where he holds the Century Mortar Club Endowed Chair in Pharmaceutical Management & Economics. Dr. Schondelmeyer is the Director of the PRIME Institute, which focuses on pharmaceutical research related to management and economics. Contact: Office: 7-159 Weaver-Densford Hall Phone: 612-624-9931 Fax: 612-625-9931

Education:

Dr. Schondelmeyer received his B.S. in Pharmacy from the University of Missouri, his Pharm.D. and clinical pharmacy residency from the University of Kentucky, and his Masters in Public Administration and Ph.D. in Pharmaceutical Administration from The Ohio State University. His work experience has encompassed activities in practice, academia, professional associations and state and federal government.

Experience:

Dr. Schondelmeyer's education, experience and background provide him with a unique understanding of the complex and technical issues leading to dramatic changes in the pharmaceutical marketplace. His expertise includes pharmacy practice management, prescription drug reimbursement, drug benefit plan management, pricing patterns of the pharmaceutical industry and pharmacoeconomics and outcomes management.

Research:

Dr. Schondelmeyer has conducted policy analysis in many areas such as reimbursement of prescription drugs under Medicaid, Medicare, managed care and other third-party programs. He was appointed to the Prescription Drug Payment Review Commission, which served in an oversight and advisory capacity to Congress for the now-repealed Medicare outpatient drug program. He has conducted research projects for a variety of sponsors including the Health Care Financing Administration, the U.S. General Accounting office (GAO), the Congressional Office of Technology Assessment (OTA), the U.S. Senate Special Committee on Aging, the Food and Drug Administration (FDA), the pharmaceutical industry and pharmacy associations.

Publications:

He has published many papers and his research has been widely quoted in the scientific, policy and public press. Quotes and citations have included: Time, U.S. News & World Report, Fortune, Forbes, The Wall Street Journal, The New York Times, The Pink Sheet, American Pharmacy, American Druggist, New England Journal of Medicine and Pharmaceutical Executive.